Literature DB >> 12829582

GPVI levels in platelets: relationship to platelet function at high shear.

Denise Best1, Yotis A Senis, Gavin E Jarvis, Helen J Eagleton, David J Roberts, Takashi Saito, Stephanie M Jung, Masaaki Moroi, Paul Harrison, Fiona R Green, Steve P Watson.   

Abstract

We have investigated the density of the collagen receptors glycoprotein VI (GPVI) and alpha 2 beta 1 on human platelets and their relationship to polymorphisms within the GPVI gene. GPVI levels varied 1.5-fold and showed a weak correlation (r = 0.35) with the levels of alpha 2 beta 1, which varied 3-fold. GPVI genotype had a significant effect on receptor levels with carriers of the proline 219 allele (approximately 22% of the population) having 10% lower GPVI levels than the more common serine homozygotes. GPVI and alpha 2 beta 1 levels were found to be significantly decreased on platelets from patients with myeloproliferative disorders (MPDs). In both the MPD and the control group, GPVI levels were found not to affect platelet function under high shear in whole blood. Similarly murine platelets that express up to 5-fold lower levels of GPVI showed no significant difference than controls in thrombus formation on a high-density collagen-coated surface. However platelets lacking the GPVI/Fc receptor gamma-chain (FcR gamma-chain) complex or a functional FcR gamma-chain (immunoreceptor tyrosine-based activation motif [ITAM] point mutant) exhibited severely abrogated thrombus formation at 800 s-1 and 1500 s-1. These results demonstrate that GPVI levels are tightly controlled and play a critical role in thrombus formation on collagen; nevertheless, a range of receptor densities can support platelet function under high shear.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829582     DOI: 10.1182/blood-2003-01-0231

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  31 in total

1.  Establishment of a flow cytometric assay for determination of human platelet glycoprotein VI based on a mouse polyclonal antibody.

Authors:  Chen-Xue Qu; Jian-Zhong Wang; Wen-Hui Wan; Chuan-Bao Li; Shu-Lan Wu
Journal:  J Clin Lab Anal       Date:  2006       Impact factor: 2.352

2.  CLEC-2 expression is maintained on activated platelets and on platelet microparticles.

Authors:  Eelo Gitz; Alice Y Pollitt; Jerney J Gitz-Francois; Osama Alshehri; Jun Mori; Samantha Montague; Gerard B Nash; Michael R Douglas; Elizabeth E Gardiner; Robert K Andrews; Christopher D Buckley; Paul Harrison; Steve P Watson
Journal:  Blood       Date:  2014-08-22       Impact factor: 22.113

3.  Hemostatic disorders in a JAK2V617F-driven mouse model of myeloproliferative neoplasm.

Authors:  Lamia Lamrani; Catherine Lacout; Véronique Ollivier; Cécile V Denis; Elizabeth Gardiner; Benoit Ho Tin Noe; William Vainchenker; Jean-Luc Villeval; Martine Jandrot-Perrus
Journal:  Blood       Date:  2014-06-20       Impact factor: 22.113

4.  The influence of N-linked glycosylation on the function of platelet glycoprotein VI.

Authors:  Thomas J Kunicki; Yann Cheli; Masaaki Moroi; Kenichi Furihata
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

5.  GPVI and alpha2beta1 play independent critical roles during platelet adhesion and aggregate formation to collagen under flow.

Authors:  Kendra L Sarratt; Hong Chen; Mary M Zutter; Samuel A Santoro; Daniel A Hammer; Mark L Kahn
Journal:  Blood       Date:  2005-05-10       Impact factor: 22.113

6.  Interspecies differences in protein expression do not impact the spatiotemporal regulation of glycoprotein VI mediated activation.

Authors:  Joanne L Dunster; Amanda J Unsworth; Alexander P Bye; Elizabeth J Haining; Marcin A Sowa; Ying Di; Tanya Sage; Chiara Pallini; Jeremy A Pike; Alexander T Hardy; Bernhard Nieswandt; Ángel García; Steve P Watson; Natalie S Poulter; Jonathan M Gibbins; Alice Y Pollitt
Journal:  J Thromb Haemost       Date:  2019-12-06       Impact factor: 5.824

7.  Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.

Authors:  Chao Fang; Evi Stavrou; Alec A Schmaier; Nadja Grobe; Mariana Morris; Andrew Chen; Marvin T Nieman; Gregory N Adams; Gretchen LaRusch; Yihua Zhou; Matthew L Bilodeau; Fakhri Mahdi; Mark Warnock; Alvin H Schmaier
Journal:  Blood       Date:  2013-02-05       Impact factor: 22.113

Review 8.  Functional significance of the platelet immune receptors GPVI and CLEC-2.

Authors:  Julie Rayes; Steve P Watson; Bernhard Nieswandt
Journal:  J Clin Invest       Date:  2019-01-02       Impact factor: 14.808

9.  Biological role of prolyl 3-hydroxylation in type IV collagen.

Authors:  Elena Pokidysheva; Sergei Boudko; Janice Vranka; Keith Zientek; Kerry Maddox; Markus Moser; Reinhard Fässler; Jerry Ware; Hans Peter Bächinger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-24       Impact factor: 11.205

10.  D-Dimer and Fibrin Degradation Products Impair Platelet Signaling: Plasma D-Dimer Is a Predictor and Mediator of Platelet Dysfunction During Trauma.

Authors:  Christopher C Verni; Antonio Davila; Carrie A Sims; Scott L Diamond
Journal:  J Appl Lab Med       Date:  2020-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.